Ural, D. D. Et Al. 2016. Neutrophil-to-lymphocyte ratio is a better marker for progression of renal dysfunction than neutrophil gelatinase associated lipocalin in heart failure. EUROPEAN JOURNAL OF HEART FAILURE , vol.18 , 397.

Ural, D. D., Argan, O., Kozdag, G., Bozyel, S., Aktas, M., Karauzum, K., ... Yilmaz, I.(2016). Neutrophil-to-lymphocyte ratio is a better marker for progression of renal dysfunction than neutrophil gelatinase associated lipocalin in heart failure. EUROPEAN JOURNAL OF HEART FAILURE , vol.18, 397.

Ural, D. Et Al. "Neutrophil-to-lymphocyte ratio is a better marker for progression of renal dysfunction than neutrophil gelatinase associated lipocalin in heart failure," EUROPEAN JOURNAL OF HEART FAILURE , vol.18, 397, 2016

Ural, D. D. Et Al. "Neutrophil-to-lymphocyte ratio is a better marker for progression of renal dysfunction than neutrophil gelatinase associated lipocalin in heart failure." EUROPEAN JOURNAL OF HEART FAILURE , vol.18, pp.397, 2016

Ural, D. D. Et Al. (2016) . "Neutrophil-to-lymphocyte ratio is a better marker for progression of renal dysfunction than neutrophil gelatinase associated lipocalin in heart failure." EUROPEAN JOURNAL OF HEART FAILURE , vol.18, p.397.

@article{article, author={D. Dilek Ural Et Al. }, title={Neutrophil-to-lymphocyte ratio is a better marker for progression of renal dysfunction than neutrophil gelatinase associated lipocalin in heart failure}, journal={EUROPEAN JOURNAL OF HEART FAILURE}, year=2016, pages={397} }